The PE Ratio as of November 2025 (TTM) for Advanced Proteome Therapeutics Corporation (APTCF) is -0.00

According to Advanced Proteome Therapeutics Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -0.00. This represents a change of -99.93% compared to the average of -4.88 of the last 4 quarters.

Advanced Proteome Therapeutics Corporation (APTCF) Historical PE Ratio (quarterly & annually)

How has APTCF PE Ratio performed in the past?

The mean historical PE Ratio of Advanced Proteome Therapeutics Corporation over the last ten years is -667.97. The current -0.00 PE Ratio has changed -99.95% with respect to the historical average. Over the past ten years (40 quarters), APTCF's PE Ratio was at its highest in in the April 2014 quarter at 3.37K. The PE Ratio was at its lowest in in the October 2013 quarter at -4158.55.

Advanced Proteome Therapeutics Corporation (APTCF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Advanced Proteome Therapeutics Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Advanced Proteome Therapeutics Corporation (APTCF) Average PE Ratio

How has APTCF PE Ratio performed in the past?

The current PE Ratio of Advanced Proteome Therapeutics Corporation (APTCF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Advanced Proteome Therapeutics Corporation (APTCF) PE Ratio vs. Peers

How is APTCF’s PE Ratio compared to its peers?

Advanced Proteome Therapeutics Corporation’s PE Ratio is less than MedMen Enterprises Inc. (-0.00), greater than Eden Empire Inc. (-0.02), greater than TRACON Pharmaceuticals, Inc. (-0.01), greater than RedHawk Holdings Corp. (-0.00), less than Predictive Technology Group, Inc. (-0.00), greater than Aladdin Healthcare Technologies SE (-0.22), greater than Hemogenyx Pharmaceuticals Plc (-5.69), greater than TuHURA Biosciences, Inc. (-1.53), less than Pivotal Therapeutics Inc. (0), greater than Propanc Biopharma, Inc. (-0.16),

Build a custom stock screener for Advanced Proteome Therapeutics Corporation (APTCF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Advanced Proteome Therapeutics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Advanced Proteome Therapeutics Corporation (APTCF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Advanced Proteome Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.